Pancreatic Cancer
Showing 1 - 25 of >10,000
Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)
Not yet recruiting
- Pancreatic Cancer
- +2 more
- DaRT seeds insertion
- (no location specified)
Sep 5, 2023
Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Modena (Olaparib 150 MG)
Recruiting
- Advanced Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Olaparib 150 MG
-
Modena, ItalyAou Modena
Oct 5, 2023
Candidates for Neoadjuvant Treatment in Resectable Pancreatic
Completed
- Pancreatic Cancer
- Neoadjuvant
- Neoadjuvant treatment
- (no location specified)
Nov 9, 2023
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen
Recruiting
- Pancreatic Cancer
- +3 more
- Bio-specimen Collection: Blood
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 21, 2023
Colorectal Cancer, Pancreatic Cancer Trial in Hangzhou (Bemalenograstim alfa)
Not yet recruiting
- Colorectal Cancer
- Pancreatic Cancer
- Bemalenograstim alfa
-
Hangzhou, Chinathe Second Affiliated Hospital of Medical College of Zhejiang Un
Nov 14, 2023
Metastatic Pancreatic Cancer, Terminal Cancer Trial in Shanghai (Ascorbate)
Recruiting
- Metastatic Pancreatic Cancer
- Terminal Cancer
-
Shanghai, Shanghai, ChinaShanghai Cancer Center
Aug 29, 2023
Pancreatic Cancer Trial in Dublin (Control, Intervention)
Not yet recruiting
- Pancreatic Cancer
- Control
- Intervention
-
Dublin, Leinster, IrelandSt Vincent's University Hospital
Nov 20, 2023
Quality of Life in Elderly Patients After Pancreatic Cancer
Recruiting
- Pancreatic Cancer
- +2 more
- Phone call
-
Lyon, FranceService de Gériatrie aigue, Hôpital Edouard Herriot, Hospices Ci
Oct 6, 2023
Pancreatic Cancer Trial in Tainan (pancreatectomy)
Completed
- Pancreatic Cancer
- pancreatectomy
-
Tainan, TaiwanNational Cheng Kung University Hospital
Oct 22, 2023
Palliative Therapy for Pancreatic Cancer Patient
Recruiting
- Pancreatic Cancer
- Observational study
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Oct 17, 2023
Pancreatic Cancer Stage IV, Chemo-induced Nausea and Vomiting Trial (Thalidomide, Nab paclitaxel, Gemcitabine)
Not yet recruiting
- Pancreatic Cancer Stage IV
- Chemotherapy-induced Nausea and Vomiting
- Thalidomide
- +2 more
- (no location specified)
Aug 24, 2023
Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable
Recruiting
- Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8
- +2 more
- Best Practice
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023
Pancreatic Cancer Trial in Nanjing (Trilaciclib+mFOLFIRINOX)
Not yet recruiting
- Pancreatic Cancer
-
Nanjing, Jiangsu, ChinaThe Affiliated Hospital of Nanjing University Medical School
Nov 21, 2023
Pancreatic Adenocarcinoma Trial (mFOLFIRINOX plus radiotherapy)
Not yet recruiting
- Pancreatic Adenocarcinoma
- mFOLFIRINOX plus radiotherapy
- (no location specified)
Nov 21, 2023
Pancreatic Adenocarcinoma, Homologous Recombination Deficiency Trial (Cisplatin)
Not yet recruiting
- Pancreatic Adenocarcinoma
- Homologous Recombination Deficiency
- (no location specified)
Oct 18, 2023
Circulating Tumor DNA in Pancreatic Cancer UsingPersonalized
Recruiting
- Pancreatic Cancer
- No intervention
-
Kashiwa, JapanNational Cancer Center Hospital East
Sep 12, 2023
Improving Pancreatic Cancer Care by Use of Computational Science
Recruiting
- Pancreatic Cancer
- +5 more
- No interventions
-
Utrecht, NetherlandsRegional Academic Cancer Center Utrecht
Sep 22, 2023
Unresectable Pancreatic Cancer Trial (creon 35.000 Ph.U (R), Best Standarard of Care)
Not yet recruiting
- Unresectable Pancreatic Cancer
- creon 35.000 Ph.U (R)
- Best Standarard of Care
- (no location specified)
Oct 19, 2023
Pancreatic Cancer Trial in ShangHai (TCR-T Cells Injection(GB3010 Cells Injection))
Recruiting
- Pancreatic Cancer
- TCR-T Cells Injection(GB3010 Cells Injection)
-
ShangHai, Shanghai, ChinaRuijin Hospital Affiliated to Shanghai Jiaotong University Schoo
Sep 19, 2023
EHR-based Pancreatic Cancer Risk Model
Active, not recruiting
- Pancreatic Adenocarcinoma
- Predictive Cancer Model
- Pancreatic Cancer Risk Model (PRISM)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 1, 2023
Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic
Enrolling by invitation
- Pancreatic
-
Shanghai, Shanghai, ChinaXinhua Hospital, Affiliated to Shanghai Jiao Tong University, Sc
Oct 25, 2023
Pancreatic Cancer Metastatic Trial (C3 (Metformin, Simvastatin, and Digoxin))
Not yet recruiting
- Pancreatic Cancer Metastatic
- C3 (Metformin, Simvastatin, and Digoxin)
- (no location specified)
Sep 1, 2023
Advanced Pancreatic Cancer Trial in Shanghai (Pimicotinib (ABSK021))
Recruiting
- Advanced Pancreatic Cancer
- Pimicotinib (ABSK021)
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Oct 26, 2023
Locally Advanced Pancreatic Cancer Trial (Stereotactic body radiation(SBRT), Zimberelimab (GLS-010))
Not yet recruiting
- Locally Advanced Pancreatic Cancer
- Stereotactic body radiation(SBRT)
- Zimberelimab (GLS-010)
- (no location specified)
Aug 22, 2023